Premium
Eledon Pharmaceuticals Inc (ELDN)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| BVF Partners L.P. | Institution | 6 385 310 | 8,26% | US$ 25,35M | 2026-03-31 |
| BlackRock, Inc. | Institution | 4 382 245 | 5,67% | US$ 17,40M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 3 855 876 | 4,99% | US$ 15,31M | 2026-03-31 |
| Defilade Capital Management, L.P. | Institution | 3 564 127 | 4,61% | US$ 14,15M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 3 293 134 | 4,26% | US$ 13,07M | 2026-03-31 |
| Armistice Capital Master Fund Ltd. | Institution | 3 137 553 | 4,06% | US$ 12,46M | 2024-12-31 |
| Armistice Capital LLC | Institution | 3 137 553 | 4,06% | US$ 12,46M | 2024-12-31 |
| Ensign Peak Advisors, Inc. | Institution | 2 464 919 | 3,19% | US$ 9,79M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 2 092 550 | 2,71% | US$ 8,31M | 2026-03-31 |
| Zimmer Partners, LP | Institution | 1 875 000 | 2,43% | US$ 7,44M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 791 783 | 2,32% | US$ 7,11M | 2026-03-31 |
| Sphera Funds Management Ltd | Institution | 1 772 131 | 2,29% | US$ 7,04M | 2026-03-31 |
| Catalio Capital Management, LP | Institution | 1 639 816 | 2,12% | US$ 6,51M | 2026-03-31 |
| CHI Advisors LLC | Institution | 1 419 912 | 1,84% | US$ 5,64M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 1 154 671 | 1,49% | US$ 4,58M | 2026-03-31 |
| AWM Investment Company Inc | Institution | 1 100 000 | 1,42% | US$ 4,37M | 2026-03-31 |
| Jefferies Financial Group Inc. | Institution | 1 094 456 | 1,42% | US$ 4,34M | 2026-03-31 |
| Kingdon Capital Management, L.L.C. | Institution | 1 039 275 | 1,34% | US$ 4,13M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 974 421 | 1,26% | US$ 3,87M | 2026-03-31 |
| Frazier Life Sciences Public Fund, L.P. | Institution | 878 080 | 1,14% | US$ 3,49M | 2024-12-31 |
| Bank of America Corporation | Institution | 869 544 | 1,12% | US$ 3,45M | 2026-03-31 |
| Sanofi | Institution | 814 980 | 1,05% | US$ 3,24M | 2026-03-31 |
| CM Management, LLC | Institution | 650 000 | 0,84% | US$ 2,58M | 2026-03-31 |
| 22NW, LP | Institution | 636 364 | 0,82% | US$ 2,53M | 2026-03-31 |
| SG Americas Securities, LLC | Institution | 635 845 | 0,82% | US$ 2,52M | 2026-03-31 |
| UBS Asset Management AG | Institution | 547 447 | 0,71% | US$ 2,17M | 2026-03-31 |
| Northern Trust Global Investments | Institution | 543 842 | 0,70% | US$ 2,16M | 2026-03-31 |
| Vanguard Fiduciary Trust Company | Institution | 503 764 | 0,65% | US$ 2,00M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 429 889 | 0,56% | US$ 1,71M | 2026-03-31 |
| Biotechnology Value Trading Fund OS LP | Institution | 307 988 | 0,40% | US$ 1,22M | 2026-03-31 |
| Medical Strategy GmbH | Institution | 294 485 | 0,38% | US$ 1,17M | 2025-06-30 |
| Frazier Life Sciences Public Overage Fund, L.P. | Institution | 258 998 | 0,34% | US$ 1,03M | 2024-12-31 |
| Goldman Sachs Asset Management, L.P. | Institution | 245 085 | 0,32% | US$ 972,99k | 2026-03-31 |
| Brevan Howard Capital Management LP | Institution | 228 557 | 0,30% | US$ 907,37k | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 194 022 | 0,25% | US$ 770,27k | 2026-03-31 |
| AQR Capital Management, LLC | Institution | 164 619 | 0,21% | US$ 653,54k | 2026-03-31 |
| BNY Asset Management | Institution | 144 148 | 0,19% | US$ 572,27k | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
